Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers
NCT04278248Phase 3Completed
- Sponsor
- Zhifei Green Bamboo
- Start
- Jan 2018
- Primary completion
- Jun 2018
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of 23-valent pneumococcal polysaccharide vaccine in Pneumococcal pneumonia (PP), sponsored by Zhifei Green Bamboo. Started Jan 2018; status: completed.
02
Drugs
23-valent pneumococcal polysaccharide vaccine
03
Conditions
Pneumococcal pneumonia (PP)
Beyond the preview
Go deeper on NCT04278248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04278248.